| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lifecore Biomedical, Inc. \de\ (LFCR) has 12 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. LFCR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 688.2K | $3.30M | - | |
| CFO | 336.7K | $1.61M | - | |
| 10% | 264.2K | $1.27M | - | |
| Other | 241.0K | $1.15M | - | |
| Dir | 138.2K | $661.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2019 | Obus Nelson | Director | Buy | 30,000 | $10.33 | $309,900.00 | +1.1% | |
| Apr 9, 2019 | Obus Nelson | Director | Buy | 30,000 | $10.33 | $310,000.00 | +0.5% | |
| Feb 8, 2019 | Obus Nelson | Director | Buy | 12,900 | $12.12 | $156,340.00 | +0.2% | |
| Feb 6, 2019 | Obus Nelson | Director | Buy | 20,000 | $12.38 | $247,600.00 | +0.7% | |
| Jan 11, 2019 | Powell Andrew Kenneth William | Director | Buy | 525 | $11.62 | $6,100.50 | +110.5% | |
| Jan 10, 2019 | Obus Nelson | Director | Buy | 20,000 | $11.33 | $226,600.00 | +0.7% | |
| Jan 10, 2019 | Sohn Catherine A.55 | Director | Buy | 1,000 | $11.23 | $11,230.00 | +4.2% | |
| Jan 8, 2019 | Carosella Deborah D | Director | Buy | 4,500 | $11.34 | $51,030.00 | +52.8% | |
| Jan 8, 2019 | Skinner Gregory S | Chief Financial Officer | Buy | 25,000 | $11.25 | $281,250.00 | +9.5% | |
| Jan 8, 2019 | Goldby Steven D | Director | Buy | 20,000 | $11.24 | $224,800.00 | +43.0% |